INTERPACE BIOSCIENCES, INC.
IDXG · OTCMCIK 1054102fmd_05W3P5J9SK5MXN1E9F2XJ6VK8BManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 13 | 16 | 22 | 24 | 32 | 33 | 32 | 40 | 47 | 39 |
| Cost of revenue | 7 | 7 | 10 | 16 | 22 | 14 | 14 | 15 | 17 | 15 |
| Net interest income | – | – | – | – | – | (0) | (0) | (0) | – | – |
| Gross profit | 6 | 9 | 12 | 8 | 11 | 19 | 18 | 25 | 30 | 24 |
| Research and development | 2 | 1 | 2 | 3 | 3 | 1 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | 16 | 16 | 17 | 25 | 27 | 20 | 20 | 20 | 21 | 19 |
| Compensation and benefits | – | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 13 | 15 | 24 | 35 | 37 | 25 | 22 | 21 | 22 | 20 |
| Operating income | (6) | (6) | (13) | (26) | (26) | (6) | (4) | 4 | 8 | 4 |
| Interest expense | 2 | 0 | 0 | 0 | 1 | – | – | – | – | – |
| Other non-operating income (expense) | 0 | (2) | 0 | 0 | 0 | (0) | (1) | (1) | – | – |
| Income before taxes | (9) | (13) | (13) | (27) | (26) | (8) | (6) | 2 | 7 | 4 |
| Income tax expense | (0) | (0) | 0 | (0) | 0 | (1) | 0 | 0 | 0 | (21) |
| Net income from continuing operations | (8) | (13) | (13) | (27) | (26) | (7) | (6) | 2 | 7 | 25 |
| Net income | (22) | 13 | (13) | (27) | (26) | (15) | (22) | 2 | 7 | 25 |
| Net income to common shareholders | – | – | (13) | (27) | (29) | (15) | – | 2 | 6 | 25 |